Congenital generalized lipodystrophy: a literature review
DOI:
https://doi.org/10.33448/rsd-v12i2.40288Keywords:
Lipodystrophy; Congenital Generalized Lipodystrophy; Metabolic syndrome.Abstract
Introduction: Congenital generalized lipodystrophy is a pathology that presents a wide range of clinical manifestations, with numerous risk factors and a high rate of complications. Objective: The objective of this work is to review the literature on congenital lipodystrophy, presenting the clinical picture, diagnosis and recommended treatment, taking into account the low incidence of reported cases and the severity of the pathology. Method: A narrative literature review was performed using the databases: PubMed, Scielo and UpToDate. The descriptors used were: “Lipodystrophy”; “Congenital Generalized Lipodystrophy”, “Insulin Resistance” and “Metabolic Syndrome”. Complete articles were selected, found in the following languages: Portuguese, English or Spanish. 298 articles were pre-selected and after verifying the inclusion and exclusion criteria, 33 studies remained that were used to compose the work. Results and discussion: Pathophysiology is associated with mutations in genes that code for different proteins, which are involved in the various stages of lipid droplet formation in adipocytes. The most reported clinical picture is related to hepatomegaly and muscle hypertrophy, but the characteristics can be variable because it is an important genetic alteration. There is a frequent association with glucose intolerance, hyperinsulinism, diabetes mellitus, hypertriglyceridemia, hepatic steatosis, prominent musculature, hypertrophic cardiomyopathy and cysts. The diagnosis is usually clinical, but needs confirmation through genetic testing. Treatment is related to the severity and complications presented by the individual. Conclusion: studies on the subject are necessary to guarantee early diagnosis and follow-up of individuals from the pediatric stage.
References
Agarwal, A. K., & Garg, A. (2006). Genetic basis of lipodystrophies and management of metabolic complications. Annual review of medicine, 57, 297–311. https://doi.org/10.1146/annurev.med.57.022605.114424
Alzu'bi, A. A., Al-Sarihin, K. K., Eteiwi, S., Al-Asaad, R. A., Al Eyadah, A. A., Khreisat, M., Al-Omari, A. A., & Haddad, F. H. (2020). Berardinelli-Seip Syndrome and Essential Thrombocytosis: An Unusual Association. Oman medical journal, 35(3), e135. https://doi.org/10.5001/omj.2020.53
Araújo-Vilar, D., & Santini, F. (2019). Diagnosis and treatment of lipodystrophy: a step-by-step approach. Journal of endocrinological investigation, 42(1), 61–73. https://doi.org/10.1007/s40618-018-0887-z
Arioglu, E., Duncan-Morin, J., Sebring, N., Rother, K. I., Gottlieb, N., Lieberman, J., Herion, D., Kleiner, D. E., Reynolds, J., Premkumar, A., Sumner, A. E., Hoofnagle, J., Reitman, M. L., & Taylor, S. I. (2000). Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Annals of internal medicine, 133(4), 263–274. https://doi.org/10.7326/0003-4819-133-4-200008150-00009
Barra, C.B., Savoldelli, R.D., Manna, T.D., Kim, C.A., Magre, J., Porta, G., Setian, N. & Damiani, D. (2011). Síndrome de Berardinelli-Seip: descrição genética e metabólica de cinco pacientes. Arquivos Brasileiros de Endocrinologia & Metabologia [online], 55(1), 54-59. https://doi.org/10.1590/S0004-27302011000100007.
Berardinelli W. (1954). An undiagnosed endocrinometabolic syndrome: report of 2 cases. The Journal of clinical endocrinology and metabolism, 14(2), 193–204. https://doi.org/10.1210/jcem-14-2-193
Brown, R. J., Araujo-Vilar, D., Cheung, P. T., Dunger, D., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., von Schnurbein, J., Sorkina, E., Stanley, T., Vigouroux, C., Wabitsch, M., Williams, R., & Yorifuji, T. (2016). The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline. The Journal of clinical endocrinology and metabolism, 101(12), 4500–4511. https://doi.org/10.1210/jc.2016-2466
Cândido Dantas, V. K., Soares, J. D. S., de Azevedo Medeiros, L. B., Craveiro Sarmento, A. S., Xavier Nobre, T. T., de Andrade, F. B., Gomes de Lima, J., & de Melo Campos, J. T. A. (2018). Nurses' knowledge about Berardinelli-Seip Congenital Lipodystrophy. PloS one, 13(6), e0197784. https://doi.org/10.1371/journal.pone.0197784
Chaves, C., Chaves, M., Anselmo, J., & César, R. (2021). Successful long-term use of pioglitazone in Berardinelli-Seip lipodystrophy-associated diabetes. Endocrinology, diabetes & metabolism case reports, 2021, 20-0183. Advance online publication. https://doi.org/10.1530/EDM-20-0183
Damasceno, É.B., Figueiredo, J.G., França, J.M.B., Veras, J.C.D., Borges, R.E.A. & Melo, L.P. (2018). Experiência de pessoas que vivem com a Síndrome de Berardinelli-Seip no Nordeste brasileiro. Ciência & Saúde Coletiva [online] 23(2), 389-398. https://doi.org/10.1590/1413-81232018232.16802017.
Dantas V.K.S.C. (2005). Síndrome de Berardinelli: territorialidade e imaginário [dissertação]. Natal: Universidade Federal do Rio Grande do Norte.
de Azevedo Medeiros, L. B., Cândido Dantas, V. K., Craveiro Sarmento, A. S., Agnez-Lima, L. F., Meireles, A. L., Xavier Nobre, T. T., de Lima, J. G., & de Melo Campos, J. T. A. (2017). High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil. Diabetology & metabolic syndrome, 9, 80. https://doi.org/10.1186/s13098-017-0280-7
Faria, C. A., Moraes, R. S., Sobral-Filho, D. C., Rego, A. G., Baracho, M. F., Egito, E. S., & Brandão-Neto, J. (2009). Autonomic modulation in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome). Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(6), 763–769. https://doi.org/10.1093/europace/eup095
Fiorenza, C. G., Chou, S. H., & Mantzoros, C. S. (2011). Lipodystrophy: pathophysiology and advances in treatment. Nature reviews. Endocrinology, 7(3), 137–150. https://doi.org/10.1038/nrendo.2010.199
Garg, A., Wilson, R., Barnes, R., Arioglu, E., Zaidi, Z., Gurakan, F., Kocak, N., O'Rahilly, S., Taylor, S. I., Patel, S. B., & Bowcock, A. M. (1999). A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. The Journal of clinical endocrinology and metabolism, 84(9), 3390–3394. https://doi.org/10.1210/jcem.84.9.6103
Garg A. (2000). Lipodystrophies. The American journal of medicine, 108(2), 143–152. https://doi.org/10.1016/s0002-9343(99)00414-3
Garg A. (2004). Acquired and inherited lipodystrophies. The New England journal of medicine, 350(12), 1220–1234. https://doi.org/10.1056/NEJMra025261
Garg, A., & Agarwal, A. K. (2009). Lipodystrophies: disorders of adipose tissue biology. Biochimica et biophysica acta, 1791(6), 507–513. https://doi.org/10.1016/j.bbalip.2008.12.014
Garg A. (2011). Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. The Journal of clinical endocrinology and metabolism, 96(11), 3313–3325. https://doi.org/10.1210/jc.2011-1159
Gomes, K. B., Pardini, V. C., & Fernandes, A. P. (2009). Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL). Clinica chimica acta; international journal of clinical chemistry, 402(1-2), 1–6. https://doi.org/10.1016/j.cca.2008.12.032
Haghighi, A., Kavehmanesh, Z., Haghighi, A., Salehzadeh, F., Santos-Simarro, F., Van Maldergem, L., Cimbalistiene, L., Collins, F., Chopra, M., Al-Sinani, S., Dastmalchian, S., de Silva, D. C., Bakhti, H., Garg, A., & Hilbert, P. (2016). Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum. Clinical genetics, 89(4), 434–441. https://doi.org/10.1111/cge.12623
Handelsman, Y., Oral, E. A., Bloomgarden, Z. T., Brown, R. J., Chan, J. L., Einhorn, D., Garber, A. J., Garg, A., Garvey, W. T., Grunberger, G., Henry, R. R., Lavin, N., Tapiador, C. D., Weyer, C., & American Association of Clinical Endocrinologists (2013). The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 19(1), 107–116. https://doi.org/10.4158/endp.19.1.v767575m65p5mr06
Hasani-Ranjbar, S., Soltani, A., Hadavi, M., Ejtahed, H.S., Mohammad-Amoli, M. & Radmard, A.R. (2017). Congenital generalized lipodystrophy in a youth presented with sclerotic and lytic bone lesions; a family with AGPAT2 mutation. Int J Pediatr;5(2):4275-4284
Herranz, P., de Lucas, R., Pérez-España, L., & Mayor, M. (2008). Lipodystrophy syndromes. Dermatologic clinics, 26(4), 569–ix. https://doi.org/10.1016/j.det.2008.05.004
Huang-Doran, I., Sleigh, A., Rochford, J. J., O'Rahilly, S., & Savage, D. B. (2010). Lipodystrophy: metabolic insights from a rare disorder. The Journal of endocrinology, 207(3), 245–255. https://doi.org/10.1677/JOE-10-0272
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., Gorden, P., & Garg, A. (2002). Leptin-replacement therapy for lipodystrophy. The New England journal of medicine, 346(8), 570–578. https://doi.org/10.1056/NEJMoa012437
Park, H. K., & Ahima, R. S. (2015). Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism: clinical and experimental, 64(1), 24–34. https://doi.org/10.1016/j.metabol.2014.08.004
Patni, N., & Garg, A. (2015). Congenital generalized lipodystrophies--new insights into metabolic dysfunction. Nature reviews. Endocrinology, 11(9), 522–534. https://doi.org/10.1038/nrendo.2015.123
Pêcheux, M. (2017). Análise do discurso. Ponte editores.
Pereira, A.S., Shitsuka, D.M., Parreira, F.J. et al. (2018). Metodologia da pesquisa cientifica. Santa Maria.
Purizaca-Rosillo, N., Mori, T., Benites-Cóndor, Y., Hisama, F. M., Martin, G. M., & Oshima, J. (2017). High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli-Seip syndrome. American journal of medical genetics. Part A, 173(2), 471–478. https://doi.org/10.1002/ajmg.a.38053
Ramanathan, N., Ahmed, M., Raffan, E., Stewart, C. L., O'Rahilly, S., Semple, R. K., Raef, H., & Rochford, J. J. (2013). Identification and Characterisation of a Novel Pathogenic Mutation in the Human Lipodystrophy Gene AGPAT2: C48R: A Novel Mutation in AGPAT2. JIMD reports, 9, 73–80. https://doi.org/10.1007/8904_2012_181
Rother, K. I., & Brown, R. J. (2013). Novel forms of lipodystrophy: why should we care? Diabetes care, 36(8), 2142–2145. https://doi.org/10.2337/dc13-0561
Seip M. (1959). Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? Acta paediatrica, 48, 555–574.
Shastry, S., Delgado, M. R., Dirik, E., Turkmen, M., Agarwal, A. K., & Garg, A. (2010). Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. American journal of medical genetics. Part A, 152A(9), 2245–2253. https://doi.org/10.1002/ajmg.a.33578
Simha V. (2014). Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy. Expert review of endocrinology & metabolism, 9(3), 205–212. https://doi.org/10.1586/17446651.2014.894877
Simha V. (2014). Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy. Expert review of endocrinology & metabolism, 9(3), 205–212. https://doi.org/10.1586/17446651.2014.894877
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mônica Bento Bispo; Ana Carolina Carli de Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
